Skip to main content

Table 3 Five-year relative survival rates for different racial groups, stratified by age, gender, and stage at diagnosis

From: Racial differences in mantle cell lymphoma in the United States

  Total (n = 5438) Non-Hispanic white (n = 4458) Hispanic white (n = 446) Black (n = 241) Asian/PI (n = 219) P-value
n Rate (95% CI) n Rate (95% CI) n Rate (95% CI) n Rate (95% CI) n Rate (95% CI)
Age group           
<40 years 75 78.0 (64.8-86.7) 48 84.7 (69.6-92.7) 12 66.8 (26.5-88.5) 11 45.5 (7.8-78.4) 3 100.0 0.7
40-64 years 2257 61.9 (59.4-64.3) 1802 63.1 (60.3-65.8) 202 51.4 (42.3-59.7) 126 58.0 (46.8-67.6) 97 61.2 (48.8-71.4) 0.523
65+ years 3106 43.2 (40.7-45.7) 2608 44.4 (41.7-47.1) 232 35.5 (26.5-44.6) 104 34.9 (22.5-47.5) 119 41.2 (29.7-52.3) 0.762
Gender           
Male 3740 51.2 (49.0-53.3) 3062 52.2 (49.8-54.5) 330 43.6 (36.0-50.9) 152 49.5 (39.0-59.2) 148 46.6 (36.4-56.2) 0.487
Female 1698 53.1 (49.9-56.1) 1396 54.9 (51.9-57.9) 116 44.4 (32.6-55.5) 89 45.4 (31.9-58.0) 71 59.5 (44.2-71.9) 0.259
Stage at diagnosis          
Stage I 633 72.6 (67.2-77.2) 518 72.9 (66.9-78.0) 46 64.2 (40.6-80.3) 27 72.1 (41.6-88.5) 33 73.7 (51.2-87.0) 0.604
Stage II 447 59.0 (52.7-64.8) 365 59.7 (52.6-66.0) 36 42.1 (18.7-64.0) 17 46.0 (14.4-73.2) 24 72.2 (45.3-87.5) 0.983
Stage III 780 45.6 (40.7-50.2) 625 46.0 (40.6-51.2) 70 39.1 (24.6-53.3) 50 40.4 (23.2-57.0) 28 62.0 (37.1-79.4) 0.143
Stage IV 3243 47.9 (45.6-50.1) 2690 49.0 (46.5-51.5) 263 39.8 (31.8-47.7) 131 45.4 (34.2-55.9) 125 37.6 (26.6-48.5) 0.063
  1. Cancers diagnosed in the period of 1992–2004 and followed up to 12/31/2009 in the SEER 18 database. In each cell, estimated rate (95% CI). P-values were generated from multivariate Cox models. Details are provided in Additional file 1.